Malaria Journal

official impact factor 3.49

Open Access Highly Access

Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

Jean-Louis A Ndiaye*, Babacar Faye, Ali Gueye, Roger Tine, Daouda Ndiaye, Corinne Tchania, Ibrahima Ndiaye, Aichatou Barry, Badara Cissé, Valérie Lameyre and Oumar Gaye

Malaria Journal 2011, 10:237 doi:10.1186/1475-2875-10-237

Accesses  

  • Last 30 days: 69 accesses
  • Last 365 days: 1620 accesses
  • All time: 1620 accesses

Cited by

BioMed Central: 2 citations

Research   Open Access

Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India

Anupkumar R Anvikar, Bhawna Sharma, Bhartendu H Shahi, Prajesh K Tyagi, Tarit K Bose, Surya K Sharma, Prakriti Srivastava, Bina Srivastava, Jean R Kiechel, Aditya P Dash, Neena Valecha Malaria Journal 2012, 11:97 (30 March 2012)

The fixed dose combination of ASAQ was found to be efficacious and safe treatment for P. falciparum malaria. The trial provides a sound basis for the use of the combination, once India opts for fixed dose combination ACT.

Research   Open Access

Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs

Bécaye Fall, Silmane Diawara, Kowry Sow, Eric Baret, Bakary Diatta, Khadidiatou B Fall, Pape S Mbaye, Fatou Fall, Yaya Diémé, Christophe Rogier, Boubacar Wade, Raymond Bercion, Bruno Pradines Malaria Journal 2011, 10:310 (20 October 2011)

The paper describes a steep reduction in the prevalence of chloroquine resistant parasites and an increase in the prevalence of mefloquine resistant parasites in the Dakar region.